Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Erlotinib Hydrochloride Market Research Report for Period 2011 to 2023 Market Share, Size, Analysis, Historical Data, Forecast and Company Profiles

Single User: $2195
Multiple User: $3195
Enterprise User: $4195

Report Summary:

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body
The global Erlotinib Hydrochloride market will reach Volume Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Raichem Lifesciences
United Biotech
CJ Corporation
Vivimed Labs
Boryung Pharmaceutical
Taj Pharmaceuticals
Natco Pharma
Intas Pharmaceuticals
RPG Life Sciences
Schwarz Pharma
Dr. Reddys Laboratories
Glenmark Pharmaceuticals
Chugai Pharmaceutical
Firma Chun Cheong
Kremers Urban Pharmaceuticals
Zuellig Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows
Non-small Cell Lung Cancer
Pancreatic Cancer
Based on region, the report describes major regions market by products and application. Regions mentioned as follows
North America
South America
Middle East Africa

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type 25mg 100mg 150mg
1.2.2 by Application Non-small Cell Lung Cancer Pancreatic Cancer
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 25mg Market, 2011-2016
4.1.2 100mg Market, 2011-2016
4.1.3 150mg Market, 2011-2016
4.2 Market Forecast
4.2.1 25mg Market Forecast, 2017-2022
4.2.2 100mg Market Forecast, 2017-2022
4.2.3 150mg Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Non-small Cell Lung Cancer Market, 2011-2016
5.1.2 Pancreatic Cancer Market, 2011-2016
5.2 Market Forecast
5.2.1 Non-small Cell Lung Cancer Market Forecast, 2017-2022
5.2.2 Pancreatic Cancer Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific Asia-Pacific Market, 2011-2016 Asia-Pacific Market by Type Asia-Pacific Market by Application
6.1.2 North America North America Market, 2011-2016 North America Market by Type North America Market by Application
6.1.3 Europe Europe Market, 2011-2016 Europe Market by Type Europe Market by Application
6.1.4 South America South America Market, 2011-2016 South America Market by Type South America Market by Application
6.1.5 Middle East Africa Middle East Africa Market, 2011-2016 Middle East Africa Market by Type Middle East Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Roche
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Cipla
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Mylan
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Teva
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 OSI Pharmaceuticals
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Glenmark Pharmaceuticals
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Beacon Pharmaceuticals
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Raichem Lifesciences
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 United Biotech
8.9.1 Profile
8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.10 CJ Corporation
8.10.1 Profile
8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.11 Vivimed Labs
8.12 Boryung Pharmaceutical
8.13 Taj Pharmaceuticals
8.14 Pharmascience
8.15 Natco Pharma
8.16 Intas Pharmaceuticals
8.17 RPG Life Sciences
8.18 Pharmascience
8.19 Schwarz Pharma
8.20 Dr. Reddys Laboratories
8.21 Glenmark Pharmaceuticals
8.22 Chugai Pharmaceutical
8.23 DKSH
8.24 Firma Chun Cheong
8.25 Kremers Urban Pharmaceuticals
8.26 Ortat
8.27 Zuellig Pharma
9 Conclusion

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Email ID:

Name of Company:




Please Enter Captcha Below:

Report Details:

Report ID: 24902

Category: 16

Published date: 2017-09-08 16:20:29

Number of Pages: 92

Publisher Name: HeyReport

Over all Rating: 84 % (Average of Ratings provided by clients)